Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 MenACYW conjugate vaccine vs Menactra in Japan
jRCT2080225192Phase 3Completed
- Start
- May 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of Meningococcal ACWY conjugate vaccine in meningococcal disease (2 arms). Primary endpoint: hSBA vaccine seroresponse for serogroups A, C, Y, and W. Started May 2020; status: completed.
02
Drugs
Meningococcal ACWY conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on jRCT2080225192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225192.